Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Role of Persistent Microvascular Obstruction by Cardiac Magnetic Resonance for ST-segment Elevation Myocardial Infarction

NCT06759532 is registered in ClinicalTrials.gov with Chinese PLA General Hospital as lead sponsor.

NCT NCT06759532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06759532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Role of Persistent Microvascular Obstruction by Cardiac Magnetic Resonance for ST-segment Elevation Myocardial Infarction
Lead sponsor
Chinese PLA General Hospital
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
October 20, 2024
Enrollment
344 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

st elevation (stemi) myocardial infarction